"long-acting" blog posts

CELT Celebrates 2024's International Day of Women and Girls in ScienceDoaa Ahmed Mohamed and Dr Lorraine Ralph are smiling at each other.

CELT Celebrates 2024's International Day of Women and Girls in Science

Sunday 11 February was International Day of Women and Girls in Science. This day was implemented in 2015 by UNESCO and UN-Women to celebrate the critical contribution of women and girls to all fields of science and technology.

Posted on: 12 February 2024

The Long-acting Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum (LAMP) Study

The Long-acting Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum (LAMP) Study

I’m Georgia Duffy, a PhD student in the Perinatal Pharmacology Group within the Centre of Excellence for Long-acting Therapeutics (CELT). I am being supervised by Dr Adeniyi Olagunju and my project is focused is Long-acting Antipsychotics for Mental Ill-health in Pregnancy and Postpartum (LAMP). My project is part of the LAMP study which is a multi-centre cohort study. Its overarching aim is to advance our understanding of the pharmacology of long-acting injectable antipsychotics (LAIA) during pregnancy and lactation.

Posted on: 12 May 2023

Invest, Innovate and Implement – How LONGEVITY can help deliver ZERO malaria

Invest, Innovate and Implement – How LONGEVITY can help deliver ZERO malaria

World Malaria Day was established to provide education and understanding of malaria. Each year the Centre of Excellence for Long-acting Therapeutics (CELT) takes this opportunity to reaffirm our commitment to revolutionising malaria prevention and control to reduce the malaria burden in low- and middle-income countries (LMICs). The theme this year is “Time to deliver zero malaria: invest, innovate, implement” – Three aspects that are critical to our strategy to reduce the malaria burden.

Posted on: 24 April 2023

Fighting on the front-line – Empowering communities to drive long-acting injectable innovation

Fighting on the front-line – Empowering communities to drive long-acting injectable innovation

The latest WHO World Malaria Report indicates that Africa carries a disproportionately high burden of malaria with 95% of malaria cases and 96% of malaria deaths occurring in this region with children under 5 accounted for about 80% of all malaria deaths on the continent. It is now more important than ever that more investment in innovation and implementation of more effective prevention strategies for low- and middle-income countries.

Posted on: 24 April 2023